Omeprazole and Cardiopulmonary failure - a phase IV clinical study of FDA data
Cardiopulmonary failure is found among people who take Omeprazole, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Omeprazole and have Cardiopulmonary failure. It is created by eHealthMe based on reports of 351,142 people who have side effects when taking Omeprazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
351,142 people reported to have side effects when taking Omeprazole.
Among them, 139 people (0.04%) have Cardiopulmonary failure.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 359,652 Omeprazole users for its effectiveness, alternative drugs and more.
What is Cardiopulmonary failure?
Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract) is found to be associated with 960 drugs and 592 conditions by eHealthMe.
Number of Omeprazole and Cardiopulmonary failure reports submitted per year:
Time on Omeprazole when people have Cardiopulmonary failure *:
Gender of people who have Cardiopulmonary failure when taking Omeprazole*:
Age of people who have Cardiopulmonary failure when taking Omeprazole *:
Common drugs people take besides Omeprazole *:
Common side effects people have besides Cardiopulmonary failure *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole and have Cardiopulmonary failure?Check whether Cardiopulmonary failure is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Cardiopulmonary failure and when was it recovered:
Expand to all the drugs that have ingredients of omeprazole:
Alternative drugs to, pros and cons of Omeprazole:
- Omeprazole (359,652 reports)
Common Omeprazole side effects:
Browse all side effects of Omeprazole:a b c d e f g h i j k l m n o p q r s t u v w x y z
Cardiopulmonary failure treatments and more:
- Cardiopulmonary failure (4,403 reports)
COVID vaccines that are related to Cardiopulmonary failure:
- Cardiopulmonary failure in Moderna COVID Vaccine
- Cardiopulmonary failure in Pfizer BioNTech Covid Vaccine
- Cardiopulmonary failure in Johnson and Johnson Covid Vaccine
Common drugs associated with Cardiopulmonary failure:
- Aspirin: 146 reports
- Avandia: 123 reports
- Furosemide: 164 reports
- Metformin: 156 reports
- Methotrexate: 151 reports
- Morphine: 111 reports
- Omeprazole: 139 reports
- Prednisone: 162 reports
- Simvastatin: 104 reports
- Sutent: 171 reports
All the drugs that are associated with Cardiopulmonary failure:
- Cardiopulmonary failure (960 drugs)
Common conditions associated with Cardiopulmonary failure:
- Arthritis - rheumatoid: 133 reports
- Diabetes: 146 reports
- Diabetes mellitus: 144 reports
- Diabetes mellitus management: 144 reports
- High blood pressure: 183 reports
- Multiple myeloma: 104 reports
- Rheumatoid arthritis: 136 reports
All the conditions that are associated with Cardiopulmonary failure:
- Cardiopulmonary failure (592 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Codeine Sulfate and Plaquenil drug interaction - 6 seconds ago
- Levothyroxine Sodium and Eye Infection - 7 seconds ago
- Cefadroxil and Periodontitis - 10 seconds ago
- Naloxone and Ofirmev drug interaction - 12 seconds ago
- Omeprazole and Psoriatic Arthropathy - 13 seconds ago
- Androgel and Tizanidine Hydrochloride drug interaction - 18 seconds ago
- Licorice and Electrocardiogram Qt Prolonged - 20 seconds ago
- Glucosamine and Letairis drug interaction - 22 seconds ago
- Capoten and Carotid Bruit - 23 seconds ago
- Sulfamethoxazole and Ubrelvy drug interaction - 25 seconds ago